H2AFZ expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.304000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.126000E-01
Normal-vs-Stage2
4.393200E-01
Normal-vs-Stage3
7.153800E-01
Normal-vs-Stage4
5.659800E-01
Stage1-vs-Stage2
6.481400E-01
Stage1-vs-Stage3
9.611000E-01
Stage1-vs-Stage4
9.627600E-01
Stage2-vs-Stage3
7.637600E-01
Stage2-vs-Stage4
7.502400E-01
Stage3-vs-Stage4
9.922200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.279600E-01
Normal-vs-AfricanAmerican
4.782000E-01
Normal-vs-Asian
4.595000E-01
Caucasian-vs-AfricanAmerican
5.984400E-01
Caucasian-vs-Asian
6.631800E-01
AfricanAmerican-vs-Asian
8.002600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.870800E-01
Normal-vs-Female
3.723800E-01
Male-vs-Female
1.245200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.148200E-01
Normal-vs-Age(41-60Yrs)
3.109000E-01
Normal-vs-Age(61-80Yrs)
5.293600E-01
Normal-vs-Age(81-100Yrs)
1.853020E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.667800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.433400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.006800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.674000E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.902600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.276000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.692600E-01
Normal-vs-Daily Drinker
4.127400E-01
Normal-vs-Weekly Drinker
5.752200E-01
Normal-vs-Occasional Drinker
2.126000E-01
Normal-vs-Social Drinker
4.512400E-01
Non Drinker-vs-Daily Drinker
7.360400E-01
Non Drinker-vs-Weekly Drinker
6.007200E-01
Non Drinker-vs-Occasional Drinker
3.134400E-01
Non Drinker-vs-Social Drinker
7.764400E-01
Daily Drinker-vs-Weekly Drinker
7.243200E-01
Daily Drinker-vs-Occasional Drinker
4.714800E-01
Daily Drinker-vs-Social Drinker
9.948000E-01
Weekly Drinker-vs-Occasional Drinker
9.862800E-01
Weekly Drinker-vs-Social Drinker
7.315000E-01
Occasional Drinker-vs-Social Drinker
5.196400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.680000E-01
Normal-vs-Grade 2
7.129000E-01
Normal-vs-Grade 3
7.245600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.553900E-02
Grade 1-vs-Grade 3
3.146200E-02
Grade 1-vs-Grade 4
6.680000E-01
Grade 2-vs-Grade 3
5.274200E-01
Grade 2-vs-Grade 4
7.129000E-01
Grade 3-vs-Grade 4
7.245600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.813600E-01
Normal-vs-NonDiabetic
3.684000E-01
Diabetic-vs-NonDiabetic
2.762400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.790300E-02
Normal-vs-NoPancreatitis
4.688000E-01
Pancreatitis-vs-NoPancreatitis
2.208000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.461400E-01
Normal-vs-N1
4.682400E-01
N0-vs-N1
4.122800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.141650E-01
Normal-vs-TP53-NonMutant
7.073800E-01
TP53-Mutant-vs-TP53-NonMutant
2.13910000002038E-06
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
